|
Originally published In Press as doi:10.1074/jbc.M005764200 on July 31, 2000
J. Biol. Chem., Vol. 275, Issue 42, 32508-32515, October 20, 2000
The Importance of the Carboxyl-terminal Domain of Cardiac
Troponin C in Ca2+-sensitive Muscle Regulation*
Melanie J.
Calvert ,
Douglas G.
Ward,
Hylary R.
Trayer, and
Ian P.
Trayer§
From the School of Biosciences, the University of Birmingham,
Edgbaston, Birmingham, B15 2TT, United Kingdom
Received for publication, June 30, 2000
 |
ABSTRACT |
The interactions between troponin I and
troponin C are central to the Ca2+-regulated control
of striated muscle. Using isothermal titration microcalorimetry we have
studied the binding of human cardiac troponin C (cTnC) and its isolated
domains to human cardiac troponin I (cTnI). We provide the first
binding data for these proteins while they are free in solution and
unmodified by reporter groups. Our data reveal that the C-terminal
domain of cTnC is responsible for most of the free energy change upon
cTnC·cTnI binding. Importantly, the interaction between cTnI
and the C-terminal domain of cTnC is 8-fold stronger in the presence of
Ca2+ than in the presence of Mg2+, suggesting
that the C-terminal domain of cTnC may play a modulatory role in
cardiac muscle regulation. Changes in the affinity of cTnI for cTnC and
its isolated C-terminal domain in response to ionic strength support
this finding, with both following similar trends. At physiological
ionic strength the affinity of cTnC for cTnI changed very little in
response to Ca2+, although the thermodynamic data show a
clear distinction between binding in the presence of Ca2+
and in the presence of Mg2+.
 |
INTRODUCTION |
Cardiac and skeletal muscle contraction is regulated by the
troponin complex and tropomyosin. The troponin complex consists of
three proteins: the Ca2+ binding subunit, troponin C
(TnC),1 the inhibitory
subunit, troponin I (TnI), and troponin T (TnT) which anchors the
troponin complex to the thin filament. The binding of Ca2+
to TnC results in conformational changes and altered interactions within the thin filament which ultimately lead to muscle contraction (1). Central to the transmission of the Ca2+ signal are
altered interactions between TnC and TnI.
Skeletal and cardiac TnC share ~70% sequence identity and consist of
two globular domains (N- and C-terminal) connected by a central helix
(2). Both proteins have four EF hand divalent cation binding sites,
sites I and II in the N-terminal domain and sites III and IV in the
C-terminal domain. All four sites bind Ca2+ in skeletal TnC
(skTnC), but in cardiac TnC (cTnC) site I is unable to bind divalent
cations (3).
Sites I and II of skTnC and site II of cTnC are low affinity
Ca2+-specific binding sites
(Ka(Ca) = 5 × 106
M 1 and 2 × 106
M 1 for skTnC and cTnC,
respectively) (4, 5). It is Ca2+ binding to these sites
which is proposed to act as the trigger for the initiation of muscle
contraction. In skTnC this involves an "opening" of the structure
with increased exposure of an extensive hydrophobic patch to which
skeletal troponin I (skTnI) binds, ultimately relieving inhibition on
actin (6). There is, however, evidence that the details of interaction
between TnC and TnI may differ in cardiac and skeletal muscle as the
Ca2+-saturated N-terminal domain of cTnC exists in a closed
conformation (7), and a recent report suggests that the binding of
cTnI147-163 is required for the "opening" of this
domain (8).
Sites III and IV in cTnC are high affinity Ca2+ binding
sites that can also bind Mg2+ with a lower affinity
(Ka(Ca) = 3 × 108
M 1 and
Ka(Mg) = 3 × 103 M 1) (5). Under
physiological conditions these sites are always occupied by
Mg2+ or Ca2+. The C-terminal domain of TnC has
been proposed as a Ca2+-independent structural binding site
for TnI and TnT, helping to anchor the troponin complex to the thin
filament (9).
Although the crystal and solution structures of skTnC and cTnC are well
characterized (2, 7, 10, 11) only low resolution data are available for
the structure of TnI (12-14). Several lines of evidence indicate that
TnI lies antiparallel to TnC and that the two proteins interact at
several sites along their length (1). The structures of skTnC bound to
skTnI1-47 and cTnC C-domain bound to the equivalent region
of cTnI (residues 33-80) show this region of TnI to be -helical and
to bind to the hydrophobic pocket of the C-terminal domain of TnC by
both polar and Van der Waals interactions (15, 16). Both of these
studies were carried out with Ca2+-saturated TnC, although
it has not been determined if the C-terminal sites are bound with
Mg2+ at all times, or if the increase in
[Ca2+] on activation is of sufficient duration to
displace Mg2+ in the contractile state. In relaxed muscle,
at low [Ca2+], interactions of the C-terminal domain of
TnC with the N-terminal region of TnI will still persist, but the
inhibitory region of TnI (residues 104-115 in skTnI, residues 136-147
in cTnI) and a region C-terminal to this (residues 140-148 in skTnI,
residues 152-199 in cTnI) are thought to bind to actin, inhibiting the actomyosin ATPase. On activation, when the regulatory site(s) of TnC
are occupied by Ca2+, these sites on TnI bind to TnC,
relieving inhibition (for review, see Ref. 17). Although much is known
about the interaction of TnI with TnC, further information is required
for us to understand fully their role in muscle regulation.
In this study isothermal titration microcalorimetry (ITC) has been used
to investigate the interaction of cTnI with cTnC and its isolated
domains. We have for the first time investigated the effect of ionic
strength and Ca2+ on the free energy, enthalpy, and entropy
changes associated with the binding of cTnC and its isolated domains to
cTnI. Our results suggest that the C-terminal domain of cTnC may play a more important role in cardiac muscle regulation than previously thought.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Restriction endonucleases, DNA-modifying enzymes,
and deoxynucleotides were purchased from New England Biolabs,
Taq polymerase was purchased from Roche Diagnostics Ltd.,
and oligonucleotide primers were produced by Alta Bioscience,
University of Birmingham. pET11c(cTnC) and pET11c(cTnI) DNA constructs
were kindly provided by Dr. E. Al-Hillawi. Inorganic chemicals were of
Analar quality from BDH Laboratory Supplies. DEAE-Sepharose Fast Flow,
CM-Sepharose Fast Flow, and Superdex 75 were obtained from Amersham
Pharmacia Biotech. BCA protein assay reagent (bicinchoninic acid) was
obtained from Pierce Chemical Company and used as per the
manufacturer's instructions.
Expression and Purification of cTnC, cTnC N-domain, and cTnC
C-domain--
Polymerase chain reaction was used to generate
DNA fragments encoding the isolated N-terminal domain of cTnC (cTnC
N-domain, residues 1-91 inclusive of N-terminal Met), and cTnC
C-domain (residues 91-161). The 5'-polymerase chain reaction primer
(5'-GGGAATTCATATGGATGACATCTACAAGGCTGC-3') for the cTnC N-domain was
designed to amplify pET11c(cTnC) DNA from the first amino acid and also
encoded an NdeI restriction site. The 3'-primer
(5'-AAGGATCCCTACCCTTTGCTGTCGTCCTT-3') corresponded to amino acids
86-91 and also encoded a stop codon upstream of a BamHI
site. To generate the cTnC C-domain a 5'-amplification primer
(5'-GGGAATTCATATGGGGAAATCTGAGGAGGAG-3') was designed to amplify the
pET11c(cTnC) DNA sequence from Gly-91 to the 3'-end of the coding
sequence. This 5'-primer also encoded an NdeI restriction site. The 3'-primer (5'-GGGGATCCCTACTCCACACCCTTCATGAAC-3') was complementary to pET11c(cTnC) DNA encoding the C terminus of cTnC; this
primer also encoded a stop codon and BamHI site.
The resulting polymerase chain reaction products were purified to a
single band by gel electrophoresis on a 7.5% polyacrylamide gel and
electroeluted. The clean products were digested with NdeI and BamHI, ligated into NdeI/BamHI-digested
pET11c vector, and used to transform competent Escherichia
coli JM101 cells. Successful clones were screened for by
restriction analysis and verified by DNA sequencing and by amino acid
sequencing of the first 10 residues of the purified protein.
The cTnC, cTnC N-domain, and cTnC C-domain pET11c constructs were
transformed into and expressed in E. coli BL21(DE3) cells. The cells were grown at 37 °C in NZCYM medium with 0.3 mM ampicillin until they reached an
A600 of 0.8-1. They were then induced
with 0.5 mM isopropyl
-D-thiogalactopyranoside and incubated for a further
4-5 h. The cells were harvested by centrifugation at 5,000 × g for 10 min. Harvested cells were homogenized into 25 mM triethanolamine hydrochloride, pH 7.5, 8 M
urea, 2 mM EDTA, 1 mM dithiothreitol. The
homogenate was then sonicated for 9 × 20 s at power level 6 using a Heatsystems Inc. sonicator. Insoluble cell debris was pelleted
by centrifugation at 75,000 × g for 40 min at 4 °C.
The cell extract was loaded onto a DEAE-Sepharose Fast Flow column (2.5 × 20 cm), equilibrated with 25 mM
triethanolamine hydrochloride, pH 7.5, 8 M urea, 2 mM EDTA, 1 mM dithiothreitol buffer, and eluted with a linear 0-0.5 M NaCl gradient. The fractions
containing cTnC or its domains were identified by absorption at 280 nm
and SDS-polyacrylamide gel electrophoresis. These fractions were
dialyzed against 1 mM ammonium bicarbonate and freeze
dried. The lyophilized protein was dissolved in 25 mM
triethanolamine hydrochloride, pH 7.5, 150 mM NaCl, 1 mM dithiothreitol, loaded on a Superdex-75 column (2.5 × 50 cm), and eluted in the same buffer. The fractions containing cTnC
or its domains were pooled and dialyzed against 1 mM
ammonium bicarbonate, freeze dried and stored at 20 °C. The
isolated proteins were judged to be ~95% pure by SDS-polyacrylamide gel electrophoresis analysis.
Expression and Purification of cTnI--
The expression of cTnI
was as described by Al-Hillawi et al. (18). Ammonium sulfate
(30% w/v) was added to cTnI cell extract in 25 mM
triethanolamine hydrochloride, pH 7.5, 8 M urea, 2 mM EDTA, 1 mM dithiothreitol buffer, and the
solution was centrifuged at 15,000 × g for 10 min. The
cTnI remained in the supernatant and was dialyzed against 25 mM triethanolamine hydrochloride, pH 7.5, 8 M
urea, 2 mM EDTA, 1 mM dithiothreitol. The cTnI
was then loaded onto a CM-Sepharose Fast Flow column (2.5 × 20 cm) equilibrated with the same buffer and eluted with a linear 0-0.5 M NaCl gradient. The fractions containing cTnI were
identified by absorption at 280 nm and SDS-polyacrylamide gel
electrophoresis, pooled, dialyzed against 1 mM HCl, freeze
dried, and stored at 20 °C.
Analytical Methods--
12% SDS-polyacrylamide gel
electrophoresis gels were run at 35 mA and stained with Coomassie Blue
(19). DNA and N-terminal protein sequencing were carried out on Applied
Biosystems 373A and 437A automated sequencers respectively by Alta
Bioscience, School of Biosciences, University of Birmingham. Protein
concentrations were determined by the bicinchoninic acid method
calibrated with bovine serum albumin (Pierce Chemical Company).
Isothermal Titration Microcalorimetry--
Experiments were
carried out using a Microcal Inc. isothermal titration
microcalorimeter. Proteins were dialyzed extensively against 20 mM MOPS, pH 7.0, 3 mM MgCl2, 0.5 mM EGTA, ± 1 mM CaCl2, with 0-0.3
M KCl and experiments performed at 30 °C. Protein
samples were clarified by centrifugation at 86,000 × g
for 20 min with a TL-100 ultracentrifuge (Beckman Instruments Co.)
prior to protein concentration determination. The sample cell was
filled with 1.4 ml of cTnI solution and titrated with cTnC, cTnC
N-domain, or cTnC C-domain. Protein concentrations were 3 µM (+Ca2+) or 6 µM
( Ca2+) cTnI solution in the cell titrated with 60 µM (+Ca2+) or 160 µM
( Ca2+) cTnC or cTnC C-domain. When cTnI was titrated with
cTnC N-domain in the presence of Ca2+ concentrations were 6 and 160 µM, respectively. The injection size was 5 µl,
with duration of 10 s, at 210-s intervals with stirring at 350 rpm. Control titrations of buffer with cTnC or its isolated domains and
titrations of cTnI with buffer indicated that heats of dilution were
small and constant. In each experiment the heat of dilution was
obtained from additional injections following complete saturation and
was subtracted from the binding isotherm. OriginTM ITC data
analysis software (Microcal Inc.) was used in the "one set of
sites" mode to analyze all binding isotherms.
Sedimentation Equilibrium--
These studies were performed with
a model E analytical ultracentrifuge (Beckman Instruments Co.) equipped
with Raleigh interference optics. The method used was the long column
meniscus depletion technique as described by Chervenka (20). An AN-D
rotor was used together with a 12-mm double-sector synthetic boundary
cell fitted with sapphire windows. All of the samples were dialyzed overnight against a buffer containing 20 mM MOPS, pH 7.0, 3 mM MgCl2, 0.5 mM EGTA ± 1 mM CaCl2 and either 0, 0.05, 0.1, or 0.3 M KCl. Protein samples were centrifuged at 86,000 × g for 20 min with a TL-100 ultracentrifuge prior to
analytical ultracentrifugation. Ultracentrifugation data were obtained
with a rotor speed of 35,000 rpm at 30 °C over a range of cTnI
concentrations from 10 to 30 µM. The interference
patterns were photographed on Kodak TSK 400 film. The developed film
was then read on a Nikon two-dimensional microcomparator. The fringe
displacement as a function of radial distance was then measured for two
fringes and the average obtained. Equilibrium was established when no
further fringe displacement occurred with time and was attained after a
6-h ultracentrifugation. The average molecular mass for the
whole solution was calculated from the slope of the plot of the natural
logarithm of the fringe displacement (lnf) against the distance from
the center of rotation squared (r2). All fringe
displacements greater than 100 µm were included in the least squares
analysis. The relationship between the Mr and
slope of the lnf versus r2 plot is
given by Equation 1,
|
(Eq. 1)
|
where R is the gas constant expressed as 8.313 J
K 1 mol 1, is the
angular velocity (2 /60 * rpm (rad. s 1)),
is the solvent density, and the partial specific volume of the
protein (0.72 g ml 1). The was calculated
from the known amino acid composition of cTnI (21). The density was
estimated using standard tables (22).
 |
RESULTS |
The Effect of Temperature on the H of cTnC·cTnI
Binding--
To determine the optimum temperature at which to monitor
cTnC·cTnI binding, the effect of temperature on the binding enthalpy was studied between 16 and 37 °C (Fig.
1). In the absence of Ca2+
(but in the presence of Mg2+) the H was +4 kJ
mol 1 at 16 °C. As the temperature was
increased, H decreased linearly to 46 kJ
mol 1 indicating exothermic binding at
physiological temperatures. The slope of this plot yields
Cp, the heat capacity of the binding process.
Cp was 2.4 ± 0.1 kJ
mol 1 K 1 in the
absence of Ca2+. These results also indicate that the
minimum temperature at which H was large enough to obtain
good data in the absence of Ca2+ was 30 °C. This
temperature was therefore used for all further experiments. In the
presence of Ca2+ the binding process was considerably more
exothermic across the entire temperature range, although
Cp was similar ( 2.2 ± 0.1 kJ
mol 1 K 1). The large
negative value of Cp upon cTnC·cTnI binding
is probably accounted for by a decrease in the solvent-exposed nonpolar
surface area (23). This could be the result of movement of apolar
residues within cTnC and/or cTnI on interaction or, more probably, the burial of hydrophobic residues at the binding interface. The fact that
Cp is very similar in the presence and
absence of Ca2+ is consistent with the binding of the cTnC
N-domain binding to cTnI being thermally neutral under these conditions
(see Fig. 5a). This suggests that the area of nonpolar
residues buried at the cTnC C-terminal domain/cTnI interface is similar
in the presence of Mg2+ or Ca2+.

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 1.
The temperature dependence of
H associated with cTnC binding to
cTnI. The H for cTnC binding to cTnI was measured at
eight temperatures. Assay conditions were 20 mM MOPS, pH
7.0, 0.3 M KCl, 3 mM MgCl2, 0.5 mM EGTA, in the absence or presence of 1 mM
CaCl2. Protein concentrations were: 6 µM cTnI
and 160 µM cTnC ( Ca2+) ( ) or 3 µM cTnI and 60 µM cTnC (+Ca2+)
( ).
|
|
Proton Release during cTnC·cTnI Binding--
If the cTnC·cTnI
binding process results in a net release or absorption of protons then
an equivalent number of protons must be absorbed or released by the
buffer. This process will contribute to the observed H
for cTnC·cTnI binding and therefore has to be accounted for. To
assess whether there is a significant absorption or release of protons
upon cTnC·cTnI complex formation H was measured in
experiments using buffers with enthalpies of ionization ranging from
2.35 to +36.51 kJ mol 1 (cacodylate, Pipes,
MOPS, and imidazole) (24). The results in Fig.
2 show that the observed H
changed very little, either in the presence or absence of
Ca2+, and was not dependent on the buffer, demonstrating
that there was little or no net release or absorption of protons during
binary complex formation.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of protonation/deprotonation on
cTnI·cTnC binding energetics. The H of cTnC
binding to cTnI was measured in buffers with different ionization
enthalpies. Assay conditions were: 20 mM buffer
(cacodylate, MOPS, imidazole, or Tris), pH 7.0, 0.3 M KCl,
3 mM MgCl2, 0.5 mM EGTA, in the
absence or presence of 1 mM CaCl2. Protein
concentrations were 6 µM cTnI and 160 µM
cTnC ( Ca2+) ( ) or 3 µM cTnI and 60 µM cTnC (+Ca2+) ( ). Each data point
represents the mean H of cTnC·cTnI binding from four
independent determinations ±S.E.
|
|
Binding of cTnC to cTnI--
Initially the experiments were
performed in the presence of 0.3 M KCl to allow comparison
with previous work (25, 26). The result of a typical ITC experiment is
illustrated in Fig. 3. A trace of the
calorimetric titration of cTnI with cTnC in the absence of
Ca2+ is shown (Fig. 3a). The negative peaks show
that the interaction is exothermic. Each deflection represents the heat
released by cTnC binding to cTnI with each injection. The binding
isotherm derived from these data is plotted in Fig. 3b. This
graph shows the integrated heats for each cTnC injection
versus the molar ratio of cTnC to cTnI. From these data the
stoichiometry (n), binding constant
(Ka) and enthalpy ( H) of binding
were obtained directly, and the changes in Gibbs free energy
( G) and entropy (T S) of binding
were calculated using Equation 2.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
Microcalorimetric titration of cTnI with
cTnC. Panel a, trace of the calorimetric titration of 6 µM cTnI with 160 µM cTnC at 30 °C, 20 mM MOPS, pH 7.0, 0.3 M KCl, 3 mM
MgCl2, 0.5 mM EGTA. Panel b, binding
isotherm obtained from the experiment shown in panel
a.
|
|
|
(Eq. 2)
|
The average Ka, H,
G, and T S values from a minimum
of five independent ITC binding experiments are given in Table
I. As expected, the
Ka was ~ 6-fold higher (17.4 × 107 M 1) in the
presence of Ca2+ than in the absence of Ca2+
(2.7 × 107 M 1).
The binding stoichiometry was essentially 1:1 under both sets of
conditions.
View this table:
[in this window]
[in a new window]
|
Table I
Binding parameters for complexation between cTnI and cTnC or cTnC
C-domain
The binding parameters were obtained from data similar to those shown
in Fig. 3. The parameters are given as the mean ± S.E. obtained
from a minimum of five independent determinations. Assay conditions
were: 20 mM MOPS, pH 7.0, 0.3 M KCl, 3 mM MgCl2, 0.5 mM EGTA ( Ca2+),
with or without 1 mM CaCl2 (+Ca2+). 6 µM ( Ca2+) or 3 µM (+Ca2+)
cTnI was titrated with 5 µl of 160 µM ( Ca2+)
or 60 µM (+Ca2+) cTnC or cTnC C-domain.
|
|
Binding of cTnI to the cTnC N- and C-domains--
Initial studies
of the binding of the cTnC N- and C-domains were carried out under
conditions identical to those employed for intact cTnC. The results
summarized in Table I show striking similarities for the thermodynamic
properties of whole cTnC and cTnC C-domain binding to cTnI. The large
negative enthalpy change drives complex formation in both cases
although there is a small entropic contribution in the absence of
Ca2+. The affinities of cTnC and cTnC C-domain for cTnI
were very similar in the presence of Ca2+ but higher than
those in the absence of Ca2+. This indicates that the
C-terminal domain of cTnC is the major contributor to the overall
binding affinity of cTnC to cTnI. We find that
Ca2+-saturated cTnC C-domain binds to cTnI with an 8 fold
higher affinity than the Mg2+-saturated cTnC C-domain.
Control binding assays with increased concentrations of
Mg2+ (up to 10 mM) gave binding parameters
identical to assays performed under standard conditions, indicating
that the cTnC C-domain was fully saturated with Mg2+ in the
presence of 3 mM Mg2+.
Attempts to monitor the binding of the isolated cTnC N-domain to cTnI
in the presence of Ca2+ proved unsuccessful in the presence
of 0.3 M KCl, even at different temperatures (data not
shown). Consequently studies were undertaken to investigate the effect
of ionic strength on the binding of whole cTnC, cTnC N- and C-domains
to cTnI.
Effect of Ionic Strength on cTnC and Its Isolated Domains Binding
to cTnI--
The effect of increasing ionic strength on the binding of
cTnC to cTnI is shown in Fig.
4a. In the absence of
Ca2+ (Mg2+ only) the affinity of cTnC for cTnI
decreased as the ionic strength was increased, whereas in the presence
of Ca2+ the affinity increased as ionic strength was
increased. Similar trends were observed when cTnI was titrated with
cTnC C-domain (Fig. 4b). In the absence of Ca2+
the affinity of the cTnC C-domain for cTnI decreased dramatically as
the ionic strength was increased, and in the presence of
Ca2+ the affinity of cTnC C-domain for cTnI increased
slightly as ionic strength was increased.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of ionic strength on the binding of
cTnC and its isolated domains to cTnI. Assay conditions were: 20 mM MOPS, pH 7.0, 3 mM MgCl2, 0.5 mM EGTA, 30 °C, with increasing KCl concentrations, in
the absence or presence of 1 mM CaCl2.
Panel a, effect of increasing ionic strength on the binding
of cTnC to cTnI. Protein concentrations were 6 µM cTnI
and 160 µM cTnC ( Ca2+) ( ) or 3 µM cTnI and 60 µM cTnC (+Ca2+)
( ). Panel b, effect of increasing ionic strength on the
binding of cTnC C-domain and cTnC N-domain to cTnI. Protein
concentrations were: 6 µM cTnI and 160 µM
cTnC C-domain ( Ca2+) ( ), 3 µM cTnI and
60 µM cTnC C-domain (+Ca2+) (×) or 6 µM cTnI and 160 µM cTnC N-domain
(+Ca2+) ( ). Each data point shown is the mean of at
least three independent determinations ± S.E.
|
|
cTnC N-domain bound to cTnI in both the presence and absence of
Ca2+ in the 0-0.1 M KCl range. In the presence
of Ca2+, binding of the cTnC N-domain to cTnI was
exothermic, equimolar, decreased slightly as ionic strength was
increased, and was ~8-fold weaker than that of the cTnC C-domain
under similar conditions (Fig. 4b). In the absence of
Ca2+, binding was endothermic and therefore must be
entropically driven. However, conditions could not be found to increase
the cTnC N-domain/cTnI stoichiometry much beyond ~0.5, making the
data difficult to interpret. The endothermic binding of cTnC N-domain
to cTnI in the absence of Ca2+ also appeared to contribute
to the binding of whole cTnC to cTnI, at concentrations of KCl less
than 0.1 M, giving rise to a two-site binding curve that
was difficult to interpret, hence these data are not shown.
Effect of Ionic Strength on Enthalpy and Entropy of
Binding--
The effect of varying the ionic strength on
H and T S of cTnC and its
isolated domains binding to cTnI resulted in the linear plots shown in
Fig. 5, a and b,
respectively. The thermodynamic parameters of cTnC C-domain binding to
cTnI closely paralleled those obtained with whole cTnC both in the
presence and absence of Ca2+ and were quite dissimilar to
those observed for the cTnC N-domain. The H observed for
cTnC N-domain binding to cTnI approached zero as the ionic strength was
increased. Because ITC monitors the heat change as a result of complex
formation a very small H made it difficult to measure
cTnC N-domain/cTnI binding affinities at ionic strengths greater than
0.1 M. The H and T S
results show that changes in enthalpy were the driving force for the
interaction between cTnC and cTnC C-domain with cTnI both in the
presence and absence of Ca2+, as both H and
T S values were negative over most of the range of salt concentrations studied. The interaction between cTnC N-domain and cTnI is entropically favorable at low salt concentrations and
entropy would be the only driving force at physiological ionic strength
(as determined from extrapolation of Fig. 5, a and
b).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of increasing ionic strength on the
enthalpy and entropy associated with the binding of cTnC and its
isolated domains to cTnI. Panel a, H, and
panel b, T S. Data were obtained
from the binding of cTnI to cTnC in the presence ( ) and absence
( ) of Ca2+, cTnC C-domain in the presence (×) and
absence ( ) of Ca2+, and cTnC N-domain the presence of
Ca2+ ( . Each data point shown is the mean of at least
three independent determinations (± S.E. shown for H).
For conditions, see the legend to Fig. 4.
|
|
Sedimentation Equilibrium Studies on cTnI--
Because of the
potential of cTnI to aggregate it was important to show that
aggregation was not the cause of differences in cTnC·cTnI binding
observed at different ionic strengths. Sedimentation equilibrium
experiments were therefore performed on cTnI under the conditions used
for ITC. A typical plot illustrating the relationship between the lnf
and the square of the distance from the axis of rotation
(r2) is shown in Fig.
6. The linear relationship of this
analysis over the entire length of the solution column demonstrates
that the cTnI is monodisperse in solution. Furthermore, this linearity was observed over all of the KCl and protein concentrations used and in
the presence and absence of Ca2+. The estimated molecular
mass obtained for cTnI by sedimentation equilibrium, by averaging the
molecular mass at all KCl conditions, was 22.6 ± 1.1 kDa (S.E.).
This agrees with the known molecular mass of cTnI (23,906 Da)
calculated from the amino acid composition and observed in this
laboratory by mass
spectrometry.2

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 6.
Sedimentation equilibrium of cTnI.
Analytical ultracentrifugation conditions were: 20 mM MOPS,
pH 7.0, 0.1 M KCl, 3 mM MgCl2, 1 mM CaCl2, 0.5 mM EGTA, 30 °C. An
AN-D rotor was used to centrifuge cTnI (20 µM) at 35,000 rpm for 7 h. The plot shows the radial distance squared
(r2) versus the lnf. The molecular
mass calculated from the linear regression of r2
versus lnf was 23,670 Da. The bottom of the cell is indicated by a
black arrow.
|
|
 |
DISCUSSION |
Fluorescence and surface plasmon resonance studies have been used
previously to establish the affinity of cTnC for cTnI, e.g. (25-28). Although these methods have provided much valuable
information, fluorescence techniques require modification of the
proteins with reporter groups, and surface plasmon resonance produces
orientation constraints because of protein immobilization. We have used
ITC, a technique for directly measuring Ka and
H values in biological systems, to examine the binding of
cTnC to cTnI under a variety of ionic conditions. No protein
modification was required, and the experiments were performed with the
proteins free in solution. Furthermore, we have studied the binding of
the recombinant N- and C-terminal domains of cTnC to cTnI. Previous
studies, using a variety of techniques, have shown that the isolated
domains of both skeletal and cardiac TnC have structures and properties very similar to those in the intact proteins (16, 29, 30).
Because it is known that TnI has a tendency toward self-association, it
was important to ascertain whether it was monomeric or forming
aggregates in solution, under the conditions used in the ITC
experiments. From the sedimentation equilibrium studies the linearity
of the graphic analysis was consistent with sample homogeneity. No
indication of dimerization or higher order aggregation was ever
observed, even in the absence of KCl, in the presence or absence of
Ca2+, with protein concentrations higher than those used
for ITC. Furthermore, previous studies from our laboratory (31) have demonstrated that both cTnC and the cTnC·cTnI complex show no tendency toward aggregation at and above the protein concentrations used in these ITC experiments. These data indicate that the protein solutions used for the ITC experiments were all monodisperse and that
effects of ionic strength on binding were not caused by protein aggregation. The fact that all observed binding ratios of cTnC (or its
isolated domains) with cTnI were essentially 1:1 under all conditions
studied is consistent with this finding.
The results show that the affinity of cTnC for cTnI is strongly
dependent on ionic strength. All previously reported measurements of
the affinity of cTnC for cTnI were obtained at concentrations of 0.3 M KCl or greater (25-28). At these high ionic strengths the affinity of cTnC for cTnI was significantly higher in the presence
of Ca2+ than in the presence of Mg2+, as we
have found here. At physiological ionic strength, however, we found no
increase in the affinity of cTnC for cTnI upon addition of
Ca2+. These data suggest that around physiological ionic
strength the cTnC/cTnI interaction in the presence and absence of
Ca2+ is finely balanced, although Ca2+ clearly
changes the mode of interaction as demonstrated by changes in
H and T S. It should be noted,
however, that we have of necessity investigated only the isolated
binary interaction between cTnC and cTnI in these studies. It is
possible that the other thin filament protein components could
influence the effect of ionic strength on the Ca2+
sensitivity of the cTnC/cTnI interaction.
We find that the effect of Ca2+ and ionic strength on the
affinity and thermodynamic parameters of the cTnC C-domain binding to
cTnI closely parallel those found with whole cTnC. These data suggest
that the C-terminal domain of cTnC dominates the steady-state interaction with cTnI in both the presence and absence of
Ca2+. These results contrast sharply with the binding of
cTnC N-domain to cTnI over the limited ionic strength range where we
were able to obtain data. Even in the presence of Ca2+ the
affinity of cTnI for the cTnC N-domain was significantly lower than
that measured for the cTnC C-domain. It is interesting to note that
where data for the binding of cTnI to the isolated domains of cTnC can
be compared with whole cTnC, considerable constraints occur in the
latter interaction. For example, at 0.1 M KCl in the
presence of Ca2+, if we consider that cTnI binds
simultaneously to both domains of TnC and that the overall affinity is
the product of the individual Ka values for both
domains, then one would expect to find a Ka for
cTnC·cTnI in the 1014
M 1 range (Fig. 5b).
Clearly the interactions of the two domains of whole cTnC with cTnI are
not independent and influence one another.
We observed that the binding of cTnC and cTnC C-domain to cTnI were
dramatically affected by the addition of Ca2+ over a range
of ionic strengths. In the absence of Ca2+, the reduction
in Ka as the ionic strength was increased, both for the C-terminal domain of cTnC and whole cTnC, may suggest that
electrostatic interactions dominate the binding when Mg2+
occupies sites III and IV. On the other hand, when Ca2+ is
bound to these sites, increasing the ionic strength increased the
affinity, especially between the intact proteins, a characteristic of
interactions in which hydrophobic forces dominate. This agrees with NMR
(16) and crystallographic data (15) that show extensive Van der Waals
interactions between TnC and TnI in the presence of Ca2+.
It also suggests a difference in the structure of the C-terminal domain
of cTnC when it is occupied by Mg2+ or Ca2+. It
may be that Ca2+ occupancy of sites III and IV "opens"
up the paired EF hands exposing hydrophobic sites as seen in the
crystal structures of skTnC (2) and skTnC bound to the N-terminal
region of skTnI (15), whereas Mg2+ is not able to do this
fully. There is presently no high resolution structure for TnC with
Mg2+ bound in sites III and IV, which would be particularly
valuable to compare with the Ca2+-bound state. Several
previous studies are consistent with our findings. Different
fluorescence changes were found within the C-terminal domain of skTnC
depending upon whether Mg2+ or Ca2+ were bound
(32, 33). Analysis of the binding of Mg2+ and
Ca2+ to cTnC by microcalorimetry suggests that
Mg2+ and Ca2+ induce different conformations of
the C-terminal domain of cTnC (34).3 Microcalorimetry has
also been used to show that conformational changes occur in the
C-terminal domain of skTnC when Ca2+ replaces
Mg2+ in sites III and IV, although these differ somewhat
from those observed in the cardiac isoform (35).
Our data demonstrate, for the first time, that there are structural
differences within the C-terminal domain of cardiac TnC, depending on whether Ca2+ or Mg2+ is bound,
which affect the characteristics of the cTnI/cTnC interaction. Experiments with skeletal isoforms also suggest
Ca2+ sensitivity in the binding of skTnC C-terminal domain
to skTnI. An increase in the affinity of a skTnC tryptic fragment,
corresponding to the C-terminal domain of skTnC, for skTnI in the
presence of Ca2+ has been noted previously (36).
Additionally, Pearlstone and Smillie (37) found that a higher ionic
strength was required to elute the C-terminal domain of skTnC from a
skTnI peptide affinity column in buffer containing Ca2+
rather than Mg2+. The difference in cTnC·cTnI affinity
would be important if Ca2+ can exchange for
Mg2+ at sites III and IV in working cardiac muscle. It has
not been determined if the C-terminal sites of TnC are bound with
Mg2+ at all times or if the Ca2+ signal is of
sufficient duration to displace Mg2+ in the contractile
state. Although modeling studies (38) suggest that Mg2+
dissociation from sites III and IV is likely to be too slow to be
completed in a single contraction-relaxation cycle, they also predict
that Ca2+ occupancy of the C-terminal domain of cTnC is a
measure of the intensity and frequency of muscle contraction and could
therefore increase with increased heart rate. This would lead to a
change in the structure of cTnC and enhanced affinity for cTnI,
allowing the C-terminal domain of cTnC to play a modulatory role in the regulation of the contractile cycle. Our results give no indication as
to whether the change in affinity of cTnC C-domain for cTnI, in the
presence and absence of Ca2+, reflects a different mode of
binding to residues 33-80 of cTnI or whether a different region of
cTnI displaces the cTnI helix at positions 33-80 in response to
Ca2+ as in the model proposed by Tripet (39).
The thermodynamic results obtained by ITC give some interesting
insights into the cTnC/cTnI interaction. Previously the G difference between Ca2+- and Mg2+-bound states
of cTnC binding to cTnI, at 0.4 M KCl, was attributed solely to Ca2+ binding to "regulatory" site II in the
N-terminal domain of cTnC (40). This change in G was
thought to be responsible for Ca2+ activation in cardiac
muscle. Our data suggest that at high ionic strengths most of the
Ca2+-dependent increase in G of
cTnC binding to cTnI arises from Ca2+ binding to sites III
and IV. Our results demonstrate that any differences between the
steady-state binding of the Mg2+ and Ca2+ forms
of cTnC to cTnI cannot solely be attributed to Ca2+ binding
to the N-terminal domain of cTnC.
Parallels can be drawn between our cTnC·cTnI work and published ITC
data on calmodulin-target peptide recognition (41, 42). Quantitatively
similar H, T S, and
Cp values and negligible proton release are
seen in both cases. The negative Cp values indicate internalization of hydrophobic surfaces upon complex formation, a process that is entropically favorable. Wintrode and
Privalov (41) considered that burial of hydrophobic surfaces could not
be the major driving force in the enthalpically driven binding of
calmodulin to target peptide. However, it cannot be excluded that the
entropy associated with the burial of hydrophobic surfaces is important
in offsetting unfavorable entropy changes arising from noncovalent bond
formation and increased order in the cTnC·cTnI complex. Both domains
of calmodulin appear to contribute similarly to the overall
H of target peptide binding (41), whereas tissue-specific
adaptations of the cardiac homolog, cTnC, to muscle regulation result
in very different contributions of the cTnC N-terminal and C-terminal
domains to the overall H.
This study has revealed the importance of ionic strength on the
cTnC/cTnI interaction, which must be considered when interpreting data.
Large changes in the H of cTnC·cTnI binding, but little change in affinity at physiological ionic strength, could imply that
the mode but not the strength of the cTnC/cTnI interaction changes in
response to Ca2+. We have also demonstrated that the
interaction between cTnC C-domain and cTnI is
Ca2+-sensitive and that cTnC C-domain is responsible for
most of the energy difference observed between cTnC·cTnI binding in
the presence and absence of Ca2+. Further studies are
required to clarify the importance of the cTnC C-domain in regulation.
It will be interesting to compare the results obtained for cTnC and its
isolated domains binding to cTnI with data obtained using the skeletal
isoforms, where significant differences in sequence and binding occur.
 |
ACKNOWLEDGEMENTS |
We thank Sue Brewer and Giles Fairhead for
the production of the cTnC C-domain and cTnC N-domain clones,
respectively. We thank Nina Sewell and Sue Brewer for technical
assistance and Dr. Rudolf Allemann and Richard Swanwick for helpful discussions.
 |
FOOTNOTES |
*
This work was supported in part by the Wellcome Trust.The costs of publication of this
article were defrayed in part by the payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of Wellcome Prize Studentship Grant 050031/Z/97/Z.
§
To whom correspondence should be addressed: School of Biosciences,
the University of Birmingham, P.O. Box 363, Edgbaston, Birmingham B15
2TT, UK. Tel.: 44-121-414-5401; Fax: 44-121-414-2597; E-mail:
i.p.trayer@bham.ac.uk.
Published, JBC Papers in Press, July 31, 2000, DOI 10.1074/jbc.M005764200
2
M. J. Calvert, D. G. Ward, P. Ashton,
and I. P. Trayer., unpublished results.
3
D. G. Ward and M. J. Calvert,
unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
TnC, troponin C;
TnI, troponin I;
TnT, troponin T;
cTnI, human cardiac troponin I;
cTnC, human cardiac troponin C;
cTnC N-domain, recombinant human cardiac
troponin C N-terminal domain (residues 1-91);
cTnC C-domain, recombinant human cardiac troponin C C-terminal domain (residues
91-161);
skTnI, troponin I from skeletal muscle;
skTnC, troponin C
from skeletal muscle;
ITC, isothermal titration microcalorimetry;
MOPS, 3-(N-morpholino)propanesulfonic acid;
lnf, logarithm of
fringe displacement;
Pipes, 1,4-piperazinediethanesulfonic acid.
 |
REFERENCES |
| 1.
|
Farah, C. S.,
and Reinach, F. C.
(1995)
FASEB J.
9,
755-767
|
| 2.
|
Herzberg, O.,
and James, M. N. G.
(1985)
Nature
313,
653-659
|
| 3.
|
Van Eerd, J.-P.,
and Takahashi, K.
(1976)
Biochemistry
15,
1171-1180
|
| 4.
|
Potter, J. D.,
and Gergely, J.
(1975)
J. Biol. Chem.
250,
4628-4635
|
| 5.
|
Holroyde, M. J.,
Robertson, S. P.,
Johnson, D. J.,
Solaro, J. R.,
and Potter, J. D.
(1980)
J. Biol. Chem.
255,
11688-11693
|
| 6.
|
Gagne, S. M.,
Tsuda, S.,
Li, M. X.,
Smillie, L. B.,
and Sykes, B. D.
(1995)
Nature Struct. Biology
2,
784-789
|
| 7.
|
Sia, S. K.,
Li, M. X.,
Spyracopoulos, L.,
Gagne, S. M.,
Liu, W.,
Putkey, J. A.,
and Sykes, B. D.
(1997)
J. Biol. Chem.
272,
18216-18221
|
| 8.
|
Li, M. X.,
Spyracopoulos, L.,
and Sykes, B. D.
(1999)
Biochemistry
38,
8289-8298
|
| 9.
|
Malnic, B.,
Farah, C. S.,
and Reinach, F. C.
(1998)
J. Biol. Chem.
273,
10594-10601
|
| 10.
|
Houdusse, A.,
Love, M. L.,
Dominguez, R.,
Grabarek, Z.,
and Cohen, C.
(1997)
Structure
5,
1695-1711
|
| 11.
|
Slupsky, C. M.,
and Sykes, B. D.
(1995)
Biochemistry
34,
15953-15964
|
| 12.
|
Olah, G. A.,
Rokop, S. E.,
Wang, C. L. A.,
Blechner, S. L.,
and Trewhella, J.
(1994)
Biochemistry
33,
8233-8239
|
| 13.
|
Olah, G. A.,
and Trewhella, J.
(1994)
Biochemistry
33,
12800-12806
|
| 14.
|
Stone, D. B.,
Timmins, P. A.,
Schneider, D. K.,
Krylova, I.,
Ramos, C. H. I.,
Reinach, F. C.,
and Mendelson, R. A.
(1998)
J. Mol. Biol.
281,
689-704
|
| 15.
|
Vassylyev, D. G.,
Takeda, S.,
Wakatsuki, S.,
Maeda, K.,
and Maeda, Y.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4847-4852
|
| 16.
|
Gasmi-Seabrook, G.,
Howarth, J. W.,
Finley, N.,
Abusamhadneh, E.,
Gaponenko, V.,
Brito, R. M. M.,
Solaro, J. R.,
and Rosevar, P. R.
(1999)
Biochemistry
38,
8313-8322
|
| 17.
|
Perry, S. V.
(1999)
Mol. Cell. Biochem.
190,
9-32
|
| 18.
|
Al-Hillawi, E.,
Minchin, S. D.,
and Trayer, I. P.
(1994)
Eur. J. Biochem.
225,
1195-1201
|
| 19.
|
Weeds, A. G.,
Hall, R.,
and Spurway, N. C.
(1975)
FEBS Lett.
49,
320-324
|
| 20.
|
Chervenka, C. H.
(1970)
Anal. Biochem.
34,
24-49
|
| 21.
|
Cohn, E. J.,
and Edsall, J. T.
(1943)
Proteins, Amino Acids and Peptides
, pp. 370-381, Reinhold Publishing Corporation, New York
|
| 22.
| Handbook of Chemistry and Physics, pp.
79
|
| 23.
|
Spolar, R. S.,
and Recordm, M. T., Jr
(1994)
Science
263,
777-784
|
| 24.
|
Christensen, J. J.,
and Hansen, L. D.
(1976)
Handbook of Proton Ionization Heats
, Wiley, New York
|
| 25.
|
Al-Hillawi, E.,
Bhandari, D.,
Trayer, H. R.,
and Trayer, I. P.
(1995)
Eur. J. Biochem.
228,
962-970
|
| 26.
|
Dong, W. J.,
Chandra, M.,
Xing, J.,
She, M. D.,
Solaro, R. J.,
and Cheung, H. C.
(1997)
Biochemistry
36,
6754-6761
|
| 27.
|
Liao, R.,
Wang, C.-K.,
and Cheung, H. C.
(1994)
Biochemistry
33,
12729-12734
|
| 28.
|
Reiffert, S.,
Jaquet, K.,
Heilmeyer, L. M. G.,
and Herberg, F. W.
(1998)
Biochemistry
37,
13516-13525
|
| 29.
|
Li, M. X.,
Chandra, M.,
Pearlstone, J. R.,
Racher, K. I.,
Trigo-Gonzalez, G.,
Borgford, T.,
Kay, C. M.,
and Smillie, L. B.
(1994)
Biochemistry
33,
917-925
|
| 30.
|
Spyracopoulos, L.,
Gagne, S. M.,
Li, M. X.,
and Sykes, B. D.
(1998)
Biochemistry
37,
18032-18044
|
| 31.
|
Bingham, R. P.
(1998)
Structural and Functional Studies of the Troponin Complex from Human Cardiac Muscle. thesis
, The University of Birmingham, Birmingham, U. K.
|
| 32.
|
Francois, J.-M.,
Sedarous, S. S.,
and Gergely, J.
(1997)
J. Muscle Res. Cell Motil.
18,
323-334
|
| 33.
|
Iio, T.,
and Kondo, H.
(1981)
J. Biochem. (Tokyo)
90,
163-175
|
| 34.
|
Kometani, K.,
and Yamada, K.
(1983)
Biochim. Biophys. Res. Commun.
114,
162-167
|
| 35.
|
Yamada, K.
(1999)
Mol. Cell. Biochem.
190,
39-45
|
| 36.
|
Swenson, C. A.,
and Fredricksen, R. S.
(1992)
Biochemistry
31,
3420-3429
|
| 37.
|
Pearlstone, J. R.,
and Smillie, L. B.
(1995)
Biochemistry
34,
6932-6940
|
| 38.
|
Robertson, S. P.,
Johnson, D. J.,
and Potter, J. D.
(1981)
Biophys. J.
34,
559-569
|
| 39.
|
Tripet, B.,
Van Eyke, J.,
and Hodges, R. S.
(1997)
J. Mol. Biol.
271,
728-750
|
| 40.
|
Liao, R.,
Wang, C.-K.,
and Cheung, H. C.
(1994)
Biochemistry
33,
12729-12734
|
| 41.
|
Wintrode, P. L.,
and Privalov, P. L.
(1997)
J. Mol. Biol.
266,
1050-1062
|
| 42.
|
Tsvetkov, P. O.,
Protasevich, I. I.,
Gilli, P.,
Lafitte, D.,
Labachov, V. M.,
Haiech, J.,
Briand, C.,
and Makarov, A. A.
(1999)
J. Biol. Chem.
274,
18161-18164
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. C. Lim, H. Yang, M. Yang, C.-K. Wang, J. Shi, E. A. Berg, D. R. Pimentel, J. K. Gwathmey, R. J. Hajjar, M. Helmes, et al.
A Novel Mutant Cardiac Troponin C Disrupts Molecular Motions Critical for Calcium Binding Affinity and Cardiomyocyte Contractility
Biophys. J.,
May 1, 2008;
94(9):
3577 - 3589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Finley and P. R. Rosevear
Introduction of Negative Charge Mimicking Protein Kinase C Phosphorylation of Cardiac Troponin I: EFFECTS ON CARDIAC TROPONIN C
J. Biol. Chem.,
December 24, 2004;
279(52):
54833 - 54840.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|